NanoVibronix, Inc. (NAOV)
USD 2.34
(0.86%)
USD 2.34
(0.86%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -3.27 Million USD | -24.54% |
| 2022 | -2.63 Million USD | 65.76% |
| 2021 | -7.68 Million USD | -8.11% |
| 2020 | -7.11 Million USD | -431.46% |
| 2019 | -1.33 Million USD | -49.33% |
| 2018 | -896 Thousand USD | 79.45% |
| 2017 | -4.36 Million USD | -4013.21% |
| 2016 | -106 Thousand USD | 93.43% |
| 2015 | -1.61 Million USD | -135.65% |
| 2014 | 4.52 Million USD | 50.25% |
| 2013 | 3.01 Million USD | 63.31% |
| 2012 | 1.84 Million USD | 230.05% |
| 2011 | 559 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -2.03 Million USD | 21.35% |
| 2024 Q1 | -2.59 Million USD | 20.99% |
| 2023 Q2 | -216 Thousand USD | 85.18% |
| 2023 FY | -3.27 Million USD | -24.54% |
| 2023 Q1 | -1.45 Million USD | 44.64% |
| 2023 Q4 | -3.27 Million USD | 13.0% |
| 2023 Q3 | -3.76 Million USD | -1644.44% |
| 2022 Q1 | -5.94 Million USD | 22.66% |
| 2022 Q3 | -1.94 Million USD | 50.29% |
| 2022 Q4 | -2.63 Million USD | -35.39% |
| 2022 FY | -2.63 Million USD | 65.76% |
| 2022 Q2 | -3.91 Million USD | 34.22% |
| 2021 Q2 | -5.65 Million USD | 28.73% |
| 2021 Q1 | -7.92 Million USD | -11.49% |
| 2021 Q3 | -8.57 Million USD | -51.84% |
| 2021 FY | -7.68 Million USD | -8.11% |
| 2021 Q4 | -7.68 Million USD | 10.39% |
| 2020 Q4 | -7.11 Million USD | -126.54% |
| 2020 Q3 | -3.13 Million USD | -2737.82% |
| 2020 FY | -7.11 Million USD | -431.46% |
| 2020 Q2 | 119 Thousand USD | 227.96% |
| 2020 Q1 | -93 Thousand USD | 93.05% |
| 2019 FY | -1.33 Million USD | -49.33% |
| 2019 Q1 | -98 Thousand USD | 89.06% |
| 2019 Q2 | -2.37 Million USD | -2319.39% |
| 2019 Q3 | -2.25 Million USD | 4.77% |
| 2019 Q4 | -1.33 Million USD | 40.74% |
| 2018 Q2 | -2.51 Million USD | 27.96% |
| 2018 FY | -896 Thousand USD | 79.45% |
| 2018 Q3 | -1.72 Million USD | 31.33% |
| 2018 Q1 | -3.49 Million USD | 19.93% |
| 2018 Q4 | -896 Thousand USD | 48.12% |
| 2017 Q3 | 1.31 Million USD | 163.45% |
| 2017 Q2 | 498 Thousand USD | 500.0% |
| 2017 Q1 | 83 Thousand USD | 178.3% |
| 2017 FY | -4.36 Million USD | -4013.21% |
| 2017 Q4 | -4.36 Million USD | -432.32% |
| 2016 FY | -106 Thousand USD | 93.43% |
| 2016 Q4 | -106 Thousand USD | 80.08% |
| 2016 Q3 | -532 Thousand USD | 33.42% |
| 2016 Q2 | -799 Thousand USD | 37.48% |
| 2016 Q1 | -1.27 Million USD | 20.82% |
| 2015 Q1 | -1.29 Million USD | -128.63% |
| 2015 Q3 | -1.99 Million USD | 11.69% |
| 2015 Q4 | -1.61 Million USD | 19.06% |
| 2015 FY | -1.61 Million USD | -135.65% |
| 2015 Q2 | -2.25 Million USD | -74.23% |
| 2014 Q3 | 4.38 Million USD | 0.0% |
| 2014 Q1 | 3.37 Million USD | 12.08% |
| 2014 Q4 | 4.52 Million USD | 3.17% |
| 2014 FY | 4.52 Million USD | 50.25% |
| 2013 Q1 | 101 Thousand USD | -94.53% |
| 2013 Q2 | 2.39 Million USD | 2266.34% |
| 2013 Q3 | 2.65 Million USD | 11.09% |
| 2013 Q4 | 3.01 Million USD | 13.48% |
| 2013 FY | 3.01 Million USD | 63.31% |
| 2012 Q4 | 1.84 Million USD | 0.0% |
| 2012 FY | 1.84 Million USD | 230.05% |
| 2011 FY | 559 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 112.104% |
| BrainsWay Ltd. | -10.32 Million USD | 68.236% |
| Cerus Corporation | 84.35 Million USD | 103.886% |
| Envoy Medical, Inc. | -3.81 Million USD | 14.053% |
| electroCore, Inc. | -9.95 Million USD | 67.072% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 36.039% |
| IceCure Medical Ltd | -9.93 Million USD | 67.002% |
| Inogen, Inc. | -103.56 Million USD | 96.835% |
| OrthoPediatrics Corp. | -9.26 Million USD | 64.627% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 9.97% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 74.971% |
| MaxCyte, Inc. | -27.76 Million USD | 88.193% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 36.202% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -469.328% |
| Orthofix Medical Inc. | 96.44 Million USD | 103.399% |
| PAVmed Inc | 29.08 Million USD | 111.27% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 80.648% |
| RxSight, Inc. | -6.68 Million USD | 50.928% |
| Sight Sciences, Inc. | -102.71 Million USD | 96.809% |
| SI-BONE, Inc. | 5.72 Million USD | 157.298% |
| TELA Bio, Inc. | -3.94 Million USD | 16.992% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 105.719% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | 1031.25% |
| Acutus Medical, Inc. | 12.27 Million USD | 126.696% |
| Talis Biomedical Corporation | -57.06 Million USD | 94.256% |
| Spectral AI, Inc. | -3.5 Million USD | 6.37% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 93.175% |
| CVRx, Inc. | -59.95 Million USD | 94.533% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 265.21% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 356.567% |
| Bioventus Inc. | 372.51 Million USD | 100.88% |
| Venus Concept Inc. | 74.3 Million USD | 104.412% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 67.806% |
| LivaNova PLC | 62.53 Million USD | 105.242% |
| 908 Devices Inc. | -115.09 Million USD | 97.152% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 101.022% |
| Nemaura Medical Inc. | 9.92 Million USD | 133.028% |
| NeuroPace, Inc. | 54.33 Million USD | 106.033% |
| LENSAR, Inc. | -18.31 Million USD | 82.099% |
| Apyx Medical Corporation | -5.15 Million USD | 36.362% |
| Cutera, Inc. | 288.3 Million USD | 101.137% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 143.619% |
| BioSig Technologies, Inc. | 262 Thousand USD | 1351.145% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 92.521% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 64.366% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 100.233% |
| Axonics, Inc. | -77.19 Million USD | 95.754% |
| Outset Medical, Inc. | 67.67 Million USD | 104.843% |
| IRIDEX Corporation | -4.28 Million USD | 23.554% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 98.159% |
| IRadimed Corporation | -47.71 Million USD | 93.131% |
| Tivic Health Systems, Inc. | -3.02 Million USD | -8.328% |
| INVO Bioscience, Inc. | 8.45 Million USD | 138.788% |
| Telesis Bio, Inc. | 32.63 Million USD | 110.044% |
| Viemed Healthcare, Inc. | -2.5 Million USD | -31.008% |
| Varex Imaging Corporation | 316.9 Million USD | 101.034% |
| Quipt Home Medical Corp. | 81.73 Million USD | 104.011% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -17.829% |
| Pulmonx Corporation | -42.36 Million USD | 92.262% |
| Dynatronics Corporation | 6.2 Million USD | 152.837% |
| Modular Medical, Inc. | -8.04 Million USD | 59.239% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 23.714% |
| Semler Scientific, Inc. | -57.13 Million USD | 94.262% |
| InMode Ltd. | -135.39 Million USD | 97.579% |
| Bruker Corporation | 891.3 Million USD | 100.368% |
| Cytosorbents Corporation | 4.18 Million USD | 178.383% |
| DexCom, Inc. | 2.02 Billion USD | 100.162% |
| Align Technology, Inc. | -840.47 Million USD | 99.61% |
| Viveve Medical, Inc. | -13.81 Million USD | 76.269% |
| ZimVie Inc. | 450.41 Million USD | 100.728% |
| Movano Inc. | -5.86 Million USD | 44.119% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 97.562% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -469.328% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 265.21% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 100.919% |
| Profound Medical Corp. | -18.17 Million USD | 81.968% |
| Insulet Corporation | 798.1 Million USD | 100.411% |
| enVVeno Medical Corporation | -2.21 Million USD | -47.791% |
| Surmodics, Inc. | -12.01 Million USD | 72.715% |
| iCAD, Inc. | -21.2 Million USD | 84.544% |
| Nuwellis, Inc. | -2.81 Million USD | -16.282% |
| Biotricity, Inc. | 23.09 Million USD | 114.195% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 103.5% |
| Aethlon Medical, Inc. | -4.5 Million USD | 27.182% |
| InspireMD, Inc. | -8.04 Million USD | 59.254% |
| PAVmed Inc. | 29.08 Million USD | 111.27% |
| BIOLASE, Inc. | 11.34 Million USD | 128.896% |
| Beyond Air, Inc. | 6.22 Million USD | 152.625% |
| FONAR Corporation | -14.66 Million USD | 77.648% |
| AxoGen, Inc. | 32.26 Million USD | 110.159% |
| Vivani Medical, Inc. | 42 Thousand USD | 7904.762% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 69.244% |
| Inari Medical, Inc. | -7.16 Million USD | 54.224% |
| UFP Technologies, Inc. | 40.77 Million USD | 108.039% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 206.823% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 31.298% |
| Tenon Medical, Inc. | -1.25 Million USD | -161.195% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 56.902% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 72.515% |
| AdaptHealth Corp. | 2.21 Billion USD | 100.148% |
| Sintx Technologies, Inc. | 905 Thousand USD | 462.21% |
| Quanterix Corporation | -132.95 Million USD | 97.535% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -17.829% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 85.343% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 100.435% |
| TransMedics Group, Inc. | 121.13 Million USD | 102.706% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 87.479% |
| NeuroMetrix, Inc. | -1.49 Million USD | -119.842% |
| Hyperfine, Inc. | -75.61 Million USD | 95.665% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 102.154% |
| Biomerica, Inc. | -3.38 Million USD | 3.161% |
| Bone Biologics Corporation | -3.02 Million USD | -8.307% |
| AVITA Medical, Inc. | -26.23 Million USD | 87.504% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | -78.306% |
| Silk Road Medical, Inc | 64.42 Million USD | 105.088% |